Top 10 Biotech Stocks to Watch in 2026
$PRME – Prime Medicine
Precision genetic medicine with deep science and long-term pipeline potential.
$RXRX – Recursion Pharmaceuticals
AI-driven drug discovery platform accelerating therapeutic development.
$ABCL – AbCellera Biologics
Antibody discovery partner with big pharma programs and diversified pipeline.
$KROS – Keros Therapeutics
Small-cap biotech showing massive year-over-year revenue growth and rapid expansion in its pipeline.
$GERN – Geron
Gene-targeting therapeutics with huge reported revenue growth metrics.
$SGMO – Sangamo Therapeutics
Cell and gene therapy company with notable growth in recent quarters.
$LXRX – Lexicon Pharmaceuticals
Clinical-stage biotech with strong growth and a diversified asset base.
$MGTX – MeiraGTx
Gene therapy developer with increasing pipeline and research expansion.
$EDIT – Editas Medicine
Gene editing biotech driving next-gen therapies with robust growth numbers.
$ENSC – Ensysce Biosciences
Ultra-small cap with huge revenue expansion — moonshot potential but high risk.